ZNF239 is a zinc finger protein that functions as a transcriptional regulator with dual DNA and RNA binding capabilities. As a member of the Krüppel-like zinc finger protein family, ZNF239 recognizes specific DNA sequences through its zinc finger domains and exhibits RNA homopolymer binding activity, suggesting roles in both transcriptional and post-transcriptional gene regulation 1. The protein localizes to nuclear ribonucleoprotein components and the nuclear matrix, consistent with its function as a DNA-binding transcription factor 2. Functionally, ZNF239 acts as a transcriptional repressor of RNA polymerase II-dependent genes, with predicted binding sites identified in promoter regions of genes involved in osteoblast differentiation 3. Clinically, ZNF239 has emerged as a significant biomarker in hepatocellular carcinoma (HCC), where it was identified as part of an RNA binding protein-related gene signature predictive of patient survival, demonstrating independent prognostic value superior to conventional clinicopathological parameters 4. Additionally, ZNF239 polymorphisms (rs10793442) have been incorporated into machine learning models for predicting osteoporosis risk, demonstrating clinical utility in bone metabolism-related disorders 5. Genetic association studies have also linked ZNF239 variants to type 2 diabetes susceptibility in admixed populations 6, suggesting broader metabolic regulatory roles.